Cognitive rehabilitation for ME/CFS brain fog
Official title: Brain Training for Chronic, Post-viral, Brain Fog: Study A
Run by University of Alabama at Birmingham · NCT07523113 · Data updated 2026-11-12
Researchers are testing two cognitive rehabilitation approaches to see which helps adults with ME/CFS and brain fog better manage thinking and daily tasks.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University of Alabama at Birmingham Academic / other |
| Locations | 1 site (Birmingham, Alabama) |
| Status | Recruiting |
| Started | June 23, 2026 |
| Main results expected | June 2027 |
| Study ends | June 2028 |
| Registry record updated | October 29, 2026 |
| Trial ID | NCT07523113 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with ME/CFS or post-viral fatigue who have mild or greater cognitive impairment and significant brain fog, able to travel for study visits and with reliable internet access.
✕Probably not a fit
Individuals without measurable cognitive impairment or those unable to participate in the in-person assessments may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares two cognitive rehabilitation methods in adults with post-viral cognitive syndrome and ME/CFS. Participants undergo online testing at set intervals and have in-person visits for blood draws and brain imaging. The trial uses randomization to assign participants to Constraint-Induced Cognitive Therapy or another training approach, delivered largely via telehealth with some in-person assessments. Procedures include brief online assessments before and after treatment and a 6-month follow-up to gauge sustained effects. Key components include processing speed training, daily living activities training, a transfer package, follow-up calls, and optional trans-auricular vagus nerve stimulation at high intensity.
Why it matters
Potential benefit: If successful, participants may experience improved processing speed, cognitive function, and daily living ability.
How similar studies have gone: Similar cognitive rehabilitation approaches have shown signal in related fatigue and cognitive impairment populations, though this exact combination is relatively novel in ME/CFS.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * diagnosis of ME/CFS that preceded cognitive complaints * mild or greater cognitive impairment * moderate or greater brain fog * some impairment in the performance of daily activities * ≥ 18 years, no upper limit if medically stable * reside in the community (as opposed to a hospital or skilled nursing facility) * able to travel to the laboratory on multiple occasions * has Internet service * has a personal computer, laptop, or tablet that can access the Internet * sufficiently fit, from both a physical and mental health perspective, to take part in the study * adequate sight and hearing to complete the UFOV test * adequate thinking skills, e.g., ability to follow directions and retain information to complete UFOV and CTAL, as marked by the judgement of the screener that the candidate is able to adequately complete the UFOV and CTAL * sufficient English proficiency (i.e., ability to speak, understand, read, and write to take part in study activities) Exclusion Criteria: * cognitive impairment due to a developmental disability, psychiatric disorder, or substance abuse, or due to another type of brain injury, such as traumatic brain injury, stroke, or a progressive brain disease, such as Alzheimer's Dementia * current substance abuse disorder * diagnosis of postural orthostatic tachycardia syndrome (POTS) by a healthcare provider * prior cognitive processing speed training on DoubleDecision or a similar program * cannot tolerate taVNS * prior history of heart attack or other serious cardiac events * implanted medical device of any type * vasovagal syncope or history of fainting * history of seizures or epilepsy * temporomandibular Joint (TMJ) syndrome or other conditions that cause substantial jaw pain * history of peripheral nerve injury to the head, neck, or face * pregnant or breastfeeding * not able or willing to get an MRI scan * not able or willing to get a blood draw
Where it's running
-
University of Alabama at Birmingham
Birmingham, Alabama, United States Recruiting
Study contacts
- Principal investigator: Gitendra Uswatte, PhD — Professor of Psychology, University of Alabama at Birmingham
- Study coordinator: Madeline Rathz, BS
- Email: mgrathz@uab.edu
- Phone: 205-934-9768
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registry for ME/CFS patients in Germany
This study is creating a large registry to collect health information from people of all ages with ME/CFS in Germany, especially those affected by long-term COVID-19 effects, to help improve understanding and treatment of the condition.
-
Nutrition-based interventions to prevent cognitive decline
This study is testing if a 6-month nutrition program can help adults at higher risk for dementia keep their thinking skills sharp.
-
Using a passive home sensor to find digital signs of brain energy changes from nicotinamide riboside
This project will try a contact-free home sensor to see if it can detect activity, sleep, and breathing changes related to nicotinamide riboside in people with mild cognitive impairment or mild Alzheimer's.
-
A program to reduce postoperative delirium in older surgical patients
This study is testing a program to see if special education and care can help prevent confusion after surgery in older patients aged 60 and above.
-
Examining brain changes in colorectal cancer patients undergoing chemotherapy
This study is trying to see how chemotherapy affects thinking and memory in people with colorectal cancer.
-
Whole-body Cryotherapy for Fatigue in ME/CFS, Fibromyalgia, Long COVID
This study tests whether brief, repeated exposure to extreme cold can help reduce fatigue and related symptoms in adults with ME/CFS, fibromyalgia, or Long COVID compared to healthy controls.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.